Axis Balanced Advantage Fund
Axis Mutual Fund · Balanced Advantage · Regular Idcw · AMFI 141645 · ISIN INF846K01A60
NAV₹13.580020 Nov 2026
3Y return—a year
5Y return—a year
Expense ratio2.17%₹3,643 Cr
Growth Score—
Returns
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch |
| Fund | — | — | — | — | — | — | — | — | — | — |
| Category middle | +6.64% | +2.36% | +6.82% | +2.96% | +2.81% | +9.31% | +8.32% | +10.10% | +9.58% | — |
Risk (36 months)
| Volatility | — |
| Sharpe | — |
| Sortino | — |
| Beta | — |
| Alpha | — |
| Deepest fall | — |
| 1-year periods with a loss | — |
| 5Y SIP XIRR | — |
Top holdings (31 Oct 2026)
| Net Receivables / (Payables) | 11.06% |
| ICICI Bank Limited | 5.59% |
| HDFC Bank Limited | 5.03% |
| Reliance Industries Limited | 3.80% |
| State Bank of India | 3.27% |
| Clearing Corporation of India Ltd | 3.22% |
| Bharti Airtel Limited | 2.68% |
| Kotak Mahindra Bank Limited | 2.65% |
| Infosys Limited | 2.33% |
| Larsen & Toubro Limited | 2.18% |
| Apollo Hospitals Enterprise Limited | 1.90% |
| Cholamandalam Investment and Finance Compa | 1.78% |
Sectors
| Banks | 19.0% |
| IT - Software | 4.2% |
| Petroleum Products | 4.1% |
| Finance | 4.0% |
| Pharmaceuticals & Biotechnology | 3.4% |
| Automobiles | 3.4% |
| Telecom - Services | 3.3% |
| Retailing | 2.8% |
Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.